Jefferies Assumes Protagonist Therapeutics (PTGX) at Buy, Sees 59% Upside
Tweet Send to a Friend
(Updated - May 25, 2023 8:52 AM EDT)
Jefferies analyst Roger Song assumes coverage on Protagonist Therapeutics (NASDAQ: PTGX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jefferies analyst Roger Song assumes coverage on Protagonist Therapeutics (NASDAQ: PTGX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
